TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. purchase Customization

purchase customization

Leave This Empty:

choose chapter to purchase


Back to Report

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Immuno-oncology Therapy
1.2 Key Market Segments
1.2.1 Immuno-oncology Therapy Segment by Type
1.2.2 Immuno-oncology Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Immuno-oncology Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Immuno-oncology Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Immuno-oncology Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Immuno-oncology Therapy Market Competitive Landscape
3.1 Global Immuno-oncology Therapy Sales by Manufacturers (2019-2024)
3.2 Global Immuno-oncology Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Immuno-oncology Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Immuno-oncology Therapy Sales Sites, Area Served, Product Type
3.6 Immuno-oncology Therapy Market Competitive Situation and Trends
3.6.1 Immuno-oncology Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Immuno-oncology Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Immuno-oncology Therapy Industry Chain Analysis
4.1 Immuno-oncology Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Immuno-oncology Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Immuno-oncology Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immuno-oncology Therapy Sales Market Share by Type (2019-2024)
6.3 Global Immuno-oncology Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Immuno-oncology Therapy Price by Type (2019-2024)
7 Immuno-oncology Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immuno-oncology Therapy Market Sales by Application (2019-2024)
7.3 Global Immuno-oncology Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Immuno-oncology Therapy Sales Growth Rate by Application (2019-2024)
8 Immuno-oncology Therapy Market Segmentation by Region
8.1 Global Immuno-oncology Therapy Sales by Region
8.1.1 Global Immuno-oncology Therapy Sales by Region
8.1.2 Global Immuno-oncology Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Immuno-oncology Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Immuno-oncology Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Immuno-oncology Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Immuno-oncology Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Immuno-oncology Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Amgen
9.1.1 Amgen Immuno-oncology Therapy Basic Information
9.1.2 Amgen Immuno-oncology Therapy Product Overview
9.1.3 Amgen Immuno-oncology Therapy Product Market Performance
9.1.4 Amgen Business Overview
9.1.5 Amgen Immuno-oncology Therapy SWOT Analysis
9.1.6 Amgen Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Immuno-oncology Therapy Basic Information
9.2.2 AstraZeneca Immuno-oncology Therapy Product Overview
9.2.3 AstraZeneca Immuno-oncology Therapy Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Immuno-oncology Therapy SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 Bristol-Myers Squibb
9.3.1 Bristol-Myers Squibb Immuno-oncology Therapy Basic Information
9.3.2 Bristol-Myers Squibb Immuno-oncology Therapy Product Overview
9.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Product Market Performance
9.3.4 Bristol-Myers Squibb Immuno-oncology Therapy SWOT Analysis
9.3.5 Bristol-Myers Squibb Business Overview
9.3.6 Bristol-Myers Squibb Recent Developments
9.4 Eli-Lilly
9.4.1 Eli-Lilly Immuno-oncology Therapy Basic Information
9.4.2 Eli-Lilly Immuno-oncology Therapy Product Overview
9.4.3 Eli-Lilly Immuno-oncology Therapy Product Market Performance
9.4.4 Eli-Lilly Business Overview
9.4.5 Eli-Lilly Recent Developments
9.5 Roche
9.5.1 Roche Immuno-oncology Therapy Basic Information
9.5.2 Roche Immuno-oncology Therapy Product Overview
9.5.3 Roche Immuno-oncology Therapy Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Immuno-oncology Therapy Basic Information
9.6.2 GlaxoSmithKline Immuno-oncology Therapy Product Overview
9.6.3 GlaxoSmithKline Immuno-oncology Therapy Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
9.7 Janssen Biotech
9.7.1 Janssen Biotech Immuno-oncology Therapy Basic Information
9.7.2 Janssen Biotech Immuno-oncology Therapy Product Overview
9.7.3 Janssen Biotech Immuno-oncology Therapy Product Market Performance
9.7.4 Janssen Biotech Business Overview
9.7.5 Janssen Biotech Recent Developments
9.8 Merck
9.8.1 Merck Immuno-oncology Therapy Basic Information
9.8.2 Merck Immuno-oncology Therapy Product Overview
9.8.3 Merck Immuno-oncology Therapy Product Market Performance
9.8.4 Merck Business Overview
9.8.5 Merck Recent Developments
9.9 Novartis
9.9.1 Novartis Immuno-oncology Therapy Basic Information
9.9.2 Novartis Immuno-oncology Therapy Product Overview
9.9.3 Novartis Immuno-oncology Therapy Product Market Performance
9.9.4 Novartis Business Overview
9.9.5 Novartis Recent Developments
9.10 Pfizer
9.10.1 Pfizer Immuno-oncology Therapy Basic Information
9.10.2 Pfizer Immuno-oncology Therapy Product Overview
9.10.3 Pfizer Immuno-oncology Therapy Product Market Performance
9.10.4 Pfizer Business Overview
9.10.5 Pfizer Recent Developments
9.11 Sanofi
9.11.1 Sanofi Immuno-oncology Therapy Basic Information
9.11.2 Sanofi Immuno-oncology Therapy Product Overview
9.11.3 Sanofi Immuno-oncology Therapy Product Market Performance
9.11.4 Sanofi Business Overview
9.11.5 Sanofi Recent Developments
9.12 Spectrum Pharmaceuticals
9.12.1 Spectrum Pharmaceuticals Immuno-oncology Therapy Basic Information
9.12.2 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Overview
9.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Market Performance
9.12.4 Spectrum Pharmaceuticals Business Overview
9.12.5 Spectrum Pharmaceuticals Recent Developments
9.13 Takeda
9.13.1 Takeda Immuno-oncology Therapy Basic Information
9.13.2 Takeda Immuno-oncology Therapy Product Overview
9.13.3 Takeda Immuno-oncology Therapy Product Market Performance
9.13.4 Takeda Business Overview
9.13.5 Takeda Recent Developments
9.14 BioNTech SE
9.14.1 BioNTech SE Immuno-oncology Therapy Basic Information
9.14.2 BioNTech SE Immuno-oncology Therapy Product Overview
9.14.3 BioNTech SE Immuno-oncology Therapy Product Market Performance
9.14.4 BioNTech SE Business Overview
9.14.5 BioNTech SE Recent Developments
9.15 Allogene Therapeutics
9.15.1 Allogene Therapeutics Immuno-oncology Therapy Basic Information
9.15.2 Allogene Therapeutics Immuno-oncology Therapy Product Overview
9.15.3 Allogene Therapeutics Immuno-oncology Therapy Product Market Performance
9.15.4 Allogene Therapeutics Business Overview
9.15.5 Allogene Therapeutics Recent Developments
9.16 IMAB-I-Mab Biopharma Co., Ltd.
9.16.1 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Basic Information
9.16.2 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Overview
9.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Market Performance
9.16.4 IMAB-I-Mab Biopharma Co., Ltd. Business Overview
9.16.5 IMAB-I-Mab Biopharma Co., Ltd. Recent Developments
9.17 Arcus Biosciences
9.17.1 Arcus Biosciences Immuno-oncology Therapy Basic Information
9.17.2 Arcus Biosciences Immuno-oncology Therapy Product Overview
9.17.3 Arcus Biosciences Immuno-oncology Therapy Product Market Performance
9.17.4 Arcus Biosciences Business Overview
9.17.5 Arcus Biosciences Recent Developments
9.18 Gritstone Oncology
9.18.1 Gritstone Oncology Immuno-oncology Therapy Basic Information
9.18.2 Gritstone Oncology Immuno-oncology Therapy Product Overview
9.18.3 Gritstone Oncology Immuno-oncology Therapy Product Market Performance
9.18.4 Gritstone Oncology Business Overview
9.18.5 Gritstone Oncology Recent Developments
9.19 Autolus Therapeutics
9.19.1 Autolus Therapeutics Immuno-oncology Therapy Basic Information
9.19.2 Autolus Therapeutics Immuno-oncology Therapy Product Overview
9.19.3 Autolus Therapeutics Immuno-oncology Therapy Product Market Performance
9.19.4 Autolus Therapeutics Business Overview
9.19.5 Autolus Therapeutics Recent Developments
9.20 Rubius Therapeutics
9.20.1 Rubius Therapeutics Immuno-oncology Therapy Basic Information
9.20.2 Rubius Therapeutics Immuno-oncology Therapy Product Overview
9.20.3 Rubius Therapeutics Immuno-oncology Therapy Product Market Performance
9.20.4 Rubius Therapeutics Business Overview
9.20.5 Rubius Therapeutics Recent Developments
10 Immuno-oncology Therapy Market Forecast by Region
10.1 Global Immuno-oncology Therapy Market Size Forecast
10.2 Global Immuno-oncology Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Immuno-oncology Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Immuno-oncology Therapy Market Size Forecast by Region
10.2.4 South America Immuno-oncology Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Immuno-oncology Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Immuno-oncology Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Immuno-oncology Therapy by Type (2025-2030)
11.1.2 Global Immuno-oncology Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Immuno-oncology Therapy by Type (2025-2030)
11.2 Global Immuno-oncology Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Immuno-oncology Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Immuno-oncology Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings